Columbia University Announces Formation of CuRAGE Therapeutics; Lead Candidate CR-3 Monoclonal Antibody Being Developed for the Treatment of Peripheral Artery Disease
Company to Present at NYC Invitation-Only VC Event Oct. 30 - October 06, 2018
Press Releases 1 - 1 of 1